Pharmaceutical dry powder composition and methods for treating respiratory tract infections
OwnerSuzana Erico Tanni MINAMOTO, Martin OHRTinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical dry powder composition for use in treating, preventing and/or amelio-rating viral infection in airways of a mammal, such as a human subject, said composition comprising micronized sodium salt as the main component and primary therapeutic agent. The present invention further provides a pharmaceutical composition for use in treating and/or ameliorating cough. The subject to be treated with the pharmaceutical composition may be infected with SARS-COV-2 and/or diagnosed with COVID-19 infection. The pharmaceutical composition is administered by dry powder inhalation.
Claims24
A dry powder composition comprising at least 50 wt % NaCl for use in preventing and/or treating a viral respiratory tract infection, wherein said composition is administered to a mammalian subject by dry powder inhalation.
Dependencies are inferred from the claim text.